Sun Pharma Advanced Research Company has confirmed that the Company is in compliance with the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and that all the disclosures required to be made under the said regulation have been made to the exchanges. They are not aware of any information which qualifies to be disclosed under the said regulation. They remain committed to make adequate and timely disclosures to the Stock Exchanges in compliance with the applicable regulations.
The above information is a part of company’s filings submitted to BSE.
